Monograph Details
|
|
Eye Disorders
> Ocular allergy/inflammation
|
|
TOBRADEX |
| Manufacturer |
|
Alcon Laboratories, Inc. |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Aminoglycoside + steroid. |
| Generic Name |
|
Tobramycin 0.3%, dexamethasone 0.1%; oph. susp; contains benzalkonium chloride. |
| Also |
|
• TOBRADEX OPH OINT
|
| Indications |
|
Ocular inflammation associated with infection or risk thereof. |
| Adults and Children |
|
≤2yrs: not recommended. ≥2yrs: 1–2 drops every 2hrs for 1st 24–48 hrs, then every 4–6 hrs. Reduce dose as condition improves; max 20mL for initial Rx. |
| Contraindications |
|
Viral, fungal, or mycobacterial infections of the eye. |
| Precautions |
|
Corneal or scleral thinning. Glaucoma. Monitor for secondary infections, intraocular pressure and cataracts in prolonged use. Monitor blood levels in combined aminoglycoside therapy. Avoid abrupt cessation. Pregnancy (Cat.C). Nursing mothers. |
| Adverse Reactions |
|
Increased intraocular pressure, cataracts, corneal perforations, optic nerve damage, delayed wound healing, secondary infection, local effects (eg, conjunctival erythema, itch, lid swelling). |
| How Supplied |
Susp—2.5mL, 5mL, 10mL
Oint—3.5g |
|
|
|
|
